Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Richards DA, Rhodes S, Ekers D, et al. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive–behavioural therapy for depression. Southampton (UK): NIHR Journals Library; 2017 Aug. (Health Technology Assessment, No. 21.46.)
Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive–behavioural therapy for depression.
Show details- Participant results newsletter - Cost and Outcome of BehaviouRal Activation (COB...Participant results newsletter - Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive–behavioural therapy for depression
- Data abstraction tables: diagnostic review - Echocardiography in newly diagnosed...Data abstraction tables: diagnostic review - Echocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation
- Scientific summary - The second Randomised Evaluation of the Effectiveness, cost...Scientific summary - The second Randomised Evaluation of the Effectiveness, cost-effectiveness and Acceptability of Computerised Therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trial
- References - Feasibility of in-home monitoring for people with glaucoma: the I-T...References - Feasibility of in-home monitoring for people with glaucoma: the I-TRAC mixed-methods study
- Spontaneous Urinary Stone Passage ENabled by Drugs case report forms - Use of dr...Spontaneous Urinary Stone Passage ENabled by Drugs case report forms - Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial)
Your browsing activity is empty.
Activity recording is turned off.
See more...